Cue Biopharma to Host Business Update Call and Webcast

BOSTON, April 02, 2024 -- Cue Biopharma, Inc. , a clinical-stage biopharmaceutical company developing a novel class of therapeutic biologics to selectively modulate disease-specific T cells,...

Related Keywords

Massachusetts ,United States ,Boston ,Jonathan Pappas ,Marie Campinell ,Cue Biopharma Inc ,International Investors ,Corporate Communications ,Nasdaq ,Lifesci Communications ,Linkedin ,Ono Pharmaceutical ,Selective Targeting ,Markets ,